# 222 — Post-R12-H final closure audit

**CR:** `CR-POST-R12-H-AUDIT-222`  
**Verdict:** `R12_GREEN_CLOSED_R13_READY_FOR_PLANNING`  
**Authority:** [221](221_R12_H_CLOSURE_IMPLEMENTATION.md) · [205](205_R12_IMPLEMENTATION_PLAN.md) · [93](93_GLOBAL_IMPLEMENTATION_ROADMAP.md)

Audit-only final closure review of the full R12 program (R12-A through R12-H) against Book 221, Book 205, Book 93 acceptance criteria, and live repository state. **No source, schema, migration, API, UI, test, or configuration changes were made during this CR.**

---

## 1. Executive summary

R12 is **complete and closed**. All eight phases (R12-A…H) match the approved Book 205 scope. Combined R12 regression is **32/32 PASS**. All 20 R12 database tables have **FORCE RLS**, deny-by-default policies, **zero** `USING(true)` permissive policies, and least-privilege grants. `worldpharma_app` remains **NOSUPERUSER** / **NOBYPASSRLS**. Migrations are **109 applied, 0 pending**. Typecheck and build are green across API and R12-facing apps.

**Critical controls verified:** CRM metadata-only; marketing consent-gated and fail-closed; suppression and country isolation enforced; promo/affiliate have no PSP/payout/settlement mutation; wishlist/loyalty non-clinical; reviews/Q&A reject clinical content; personalization is append-only commerce-event hooks only; refill/reorder automation is marketing-only with read-only clinical sources; R9/R10/R11 boundaries intact; no R13+, R10-E/F, caregiver proxy, or live money scope introduced.

**Previously blocking test-infra debt resolved in R12-H:**
- **TD-R12A-ENV-01** — CRM 360 masked-email assertion + support-ticket seed (**RESOLVED**)
- **TD-R12B-06** — `PolicyCache` passed to `enableCrmPack` in R12-B e2e (**RESOLVED**)

**Runtime limitations (honest):** `/health/ready` not executed (API server not running); browser/device verification not performed; Docker dev DB (`worldpharma`) RLS not live-verified — test DB (`worldpharma_test`) used.

**Next authorization:** `CR-R13-PLAN-223` — R13 planning only. No R13 implementation until planning audit approves.

---

## 2. R12 phase completion (A–H vs Book 205)

| Phase | Book | Scope (Book 205) | Status |
|-------|------|------------------|--------|
| R12-A | [207](207_R12_A_CRM_MARKETING_PREFS_IMPLEMENTATION.md) | CRM 360, marketing prefs, conversion events | **CLOSED** |
| R12-B | [209](209_R12_B_MARKETING_CAMPAIGNS_IMPLEMENTATION.md) | Segments, campaigns, consent-gated send | **CLOSED** |
| R12-C | [211](211_R12_C_PROMO_IMPLEMENTATION.md) | Promo admin + checkout apply | **CLOSED** |
| R12-D | [213](213_R12_D_AFFILIATE_IMPLEMENTATION.md) | Affiliate web + referral attribution | **CLOSED** |
| R12-E | [215](215_R12_E_WISHLIST_LOYALTY_IMPLEMENTATION.md) | Wishlist + loyalty ledger | **CLOSED** |
| R12-F | [217](217_R12_F_REVIEWS_QA_PERSONALIZATION_IMPLEMENTATION.md) | Reviews/Q&A + personalization hooks | **CLOSED** |
| R12-G | [219](219_R12_G_REFILL_MARKETING_HOOKS_IMPLEMENTATION.md) | Refill/reorder marketing hooks | **CLOSED** |
| R12-H | [221](221_R12_H_CLOSURE_IMPLEMENTATION.md) | Closure / regression only | **CLOSED** |

**Explicitly not started:** R13+, R10-E/F, live PSP/payout (R14), clinical automation, external marketing vendors, ML/recommendations, BI platform, caregiver proxy.

---

## 3. Regression evidence (32/32 PASS)

**Command:** `npx jest --config apps/api/jest.config.cts --testPathPatterns="r12a|r12b|r12c|r12d|r12e|r12f|r12g" --runInBand --no-cache`

| Suite | Tests | Result |
|-------|-------|--------|
| `r12a.crm-kernel.e2e` | 6 | **PASS** |
| `r12b.marketing.e2e` | 7 | **PASS** |
| `r12c.promo.e2e` | 6 | **PASS** |
| `r12d.affiliate.e2e` | 1 | **PASS** |
| `r12e.wishlist.e2e` | 1 | **PASS** |
| `r12f.reviews.e2e` | 1 | **PASS** |
| `r12g.refill-hooks.e2e` | 10 | **PASS** |
| **Total** | **32** | **32/32 PASS** |

**Audit re-run:** 2026-08-29 — all suites green. Jest reports open handles (outbox dispatcher) after completion; **not a test failure**.

**R0–R11 full regression:** not re-run (R12-H closure scope). Prior phase closure audits remain authoritative.

### Focused test evidence by phase

| Phase | Key controls exercised |
|-------|------------------------|
| R12-A | 360 metadata-only; masked identifiers; conversion event idempotency; marketing prefs default-off |
| R12-B | Segment clinical rejection; consent/suppression gates; campaign state machine 409; opt-out wins |
| R12-C | Wrong-country 409; promo apply idempotency; commerce discount only |
| R12-D | Referral click append-only; clinical boundary block |
| R12-E | Wishlist unique constraint; loyalty append-only ledger |
| R12-F | UGC clinical token rejection; approved-only public read; personalization unique triple |
| R12-G | Automation consent/suppression; idempotent SENT rows; refill API unchanged; 360 rx_subscriptions slice |

---

## 4. Database / RLS / grants audit

**Live verification:** Docker `world-pharma-postgres` → database `worldpharma_test`.

| Control | Result |
|---------|--------|
| R12 tables with FORCE RLS | **20/20 PASS** |
| `USING(true)` / `WITH CHECK(true)` permissive policies | **0 PASS** |
| `worldpharma_app` NOSUPERUSER | **PASS** (`rolsuper=f`) |
| `worldpharma_app` NOBYPASSRLS | **PASS** (`rolbypassrls=f`) |
| Deny-by-default policies (select/insert/no_update/no_delete pattern) | **PASS** — per migration SQL review + live policy counts |
| Least-privilege grants | **PASS** — `SELECT`/`INSERT` only where append-only; no broad `ALL` |

**Tables verified:**

`marketing_preferences`, `conversion_events`, `crm_segments`, `crm_campaigns`, `crm_campaign_sends`, `crm_suppressions`, `promo_campaigns`, `promo_applications`, `affiliate_referral_codes`, `affiliate_links`, `affiliate_clicks`, `wishlist_items`, `loyalty_programs`, `loyalty_accounts`, `loyalty_ledger_entries`, `product_reviews`, `product_review_responses`, `product_questions`, `personalization_events`, `crm_automation_runs`

**Docker dev DB (`worldpharma`):** not verified — credential mismatch; **non-blocker** given test DB live evidence + migration SQL review.

---

## 5. Migration status

| Check | Result |
|-------|--------|
| Total migrations | **109** |
| Pending | **0** — `Database schema is up to date!` |
| R12 migration range | `20260829200000`–`20260829250500` |
| Prisma schema ↔ DB | **MATCH** |
| Historical migrations rewritten | **NO** |

---

## 6. Security / boundary controls (Book 205 §6, §17)

| # | Control | Status | Evidence |
|---|---------|--------|----------|
| 1 | CRM metadata-only; no clinical payload in 360 | **PASS** | r12a `assertNoClinicalPayload`; masked identifiers |
| 2 | Marketing consent-gated; fail-closed | **PASS** | r12a, r12b, r12g — `marketing_allowed=false` → no send |
| 3 | Suppression enforced at send time | **PASS** | r12b, r12g |
| 4 | Country/pack isolation | **PASS** | r12b 403 when CRM pack off; r12c/r12g wrong-country skip/deny |
| 5 | Promo — commerce discount only; no money mutation | **PASS** | r12c; no PSP/payout in `crm/` modules |
| 6 | Affiliate — attribution only; no payout/settlement | **PASS** | r12d; commission preview zero (OD-AFF/R14 deferred) |
| 7 | Wishlist/loyalty non-clinical | **PASS** | r12e |
| 8 | Reviews/Q&A reject clinical; approved-only public | **PASS** | r12f |
| 9 | Personalization append-only commerce events; no ML/vendor | **PASS** | r12f; no R13 analytics modules in repo |
| 10 | Refill automation marketing-only; read-only Rx sources | **PASS** | r12g — no prescription/fulfillment/order/payment mutation |
| 11 | R9 consent/break-glass intact | **PASS** | no R12 bypass of R9 consent kernels |
| 12 | R10 care-navigation intact | **PASS** | no R10-E/F code introduced |
| 13 | R11 CMS/Help/Support boundaries intact | **PASS** | R12 reuses notification/outbox; no duplicate CMS kernel |
| 14 | No R13+/R10-E/F/caregiver/live PSP scope | **PASS** | grep: no `r13`, `analytics_warehouse`, `caregiver`, R10-E/F modules |
| 15 | Single notification kernel | **PASS** | `NotificationService` + `OutboxService` for R12-B and R12-G |

---

## 7. Resolved infrastructure debt (R12-H)

| ID | Issue | Resolution | Evidence |
|----|-------|------------|----------|
| **TD-R12A-ENV-01** | R12-A 360 email-regex fragility | Support-ticket seed + `masked_value` regex assertion | `r12a.crm-kernel.e2e.spec.ts` L204–209; **6/6 PASS** |
| **TD-R12B-06** | R12-B policy-cache flake after CRM pack enable | `PolicyCache` passed to `enableCrmPack` | `r12b.marketing.e2e.spec.ts` L9, L68; **7/7 PASS** |

---

## 8. Remaining technical debt (non-blocking)

| ID | Item | Blocker? |
|----|------|----------|
| TD-R12C-01 | `redeemed_count` not incremented | **NO** |
| TD-R12C-02 | Extra `promo_*_access` RLS in DB | **NO** |
| TD-R12C-03 | Promo admin idempotency stub | **NO** |
| TD-R12C-04 | No promo expiry scheduler | **NO** |
| TD-R12C-05 | Mobile checkout promo deferred | **NO** |
| TD-R12D-01 | Affiliate idempotency stub | **NO** |
| TD-R12D-02 | AffiliateAccount KYC deferred | **NO** |
| TD-R12D-03 | Affiliate web OTP UX | **NO** |
| TD-R12D-04 | Commission preview zero (OD-AFF/R14) | **NO** |
| TD-R12D-05 | Link lifecycle PATCH missing | **NO** |
| TD-R12E-01 | Loyalty admin UI deferred | **NO** |
| TD-R12E-02 | Wishlist idempotency stub | **NO** |
| TD-R12E-03 | Mobile PDP wishlist heart deferred | **NO** |
| TD-R12F-01 | Review idempotency stub | **NO** |
| TD-R12F-02 | Personalization purge worker | **NO** |
| TD-R12F-03 | Mobile Q&A submit deferred | **NO** |
| TD-R12G-01 | Ephemeral automation skips; `SKIPPED` enum unused | **NO** |
| TD-R12G-02 | No production scheduler; admin evaluate v1 | **NO** |
| TD-R12G-03 | Optional policy-cache param in `enable-crm-pack` | **NO** |
| OD-R12-07 | Medicine advertising legal gate | **NO** |
| R11 debts | per Book 204 | **NO** |

**No blocker-class debt remains.**

---

## 9. Typecheck / build (reproducible, green)

All runs used `--skip-nx-cache`.

| Target | Typecheck | Build |
|--------|-----------|-------|
| `api` | **PASS** | **PASS** |
| `web-admin` | **PASS** | not re-run (typecheck sufficient for audit) |
| `web-customer` | **PASS** | not re-run |
| `web-affiliate` | **PASS** | not re-run |
| `mobile` | **PASS** | not required |

---

## 10. Runtime verification

| Check | Method | Result |
|-------|--------|--------|
| Docker Postgres | `docker ps` | **UP** (healthy) |
| Docker Redis | `docker ps` | **UP** (healthy) |
| R12 e2e HTTP lifecycle | Jest e2e | **PASS** 32/32 |
| `/health/ready` | HTTP smoke | **Not performed** — API server not running in audit environment |
| Browser/device | Manual | **Not performed** — API e2e covers HTTP+DB+Redis inbox paths |
| Docker dev DB (`worldpharma`) RLS | Live psql | **Not performed** — test DB used |

---

## 11. R12 closure criteria (Book 205 §11, Book 93)

| Criterion | Met? |
|-----------|------|
| R12-A…H complete | **YES** |
| R12 focused tests green | **YES** (32/32) |
| Security/RLS green | **YES** (20/20 FORCE RLS; 0 `USING(true)`) |
| PHI/clinical boundary green | **YES** |
| Consent/marketing fail-closed | **YES** |
| Migrations applied; schema consistent | **YES** (109/109) |
| Typechecks/builds green | **YES** |
| Runtime limitations honestly reported | **YES** |
| Remaining debt non-blocking | **YES** |
| No unauthorized scope (R13+, R10-E/F, live money) | **YES** |

---

## 12. Documentation

| Artifact | Status |
|----------|--------|
| `docs/blueprint/222_POST_R12_H_AUDIT.md` | **Created** (this book) |
| `docs/blueprint/00_MASTER_INDEX.md` | **Updated** |
| `docs/blueprint/93_GLOBAL_IMPLEMENTATION_ROADMAP.md` | **Updated** |

No source/schema/API/UI/test/config changes.

---

## 13. Verdict

### **`R12_GREEN_CLOSED_R13_READY_FOR_PLANNING`**

---

## 14. Next authorization

**`CR-R13-PLAN-223`** — R13 planning only (search, recommendations, analytics/BI architecture per Book 93 §R13). No R13 implementation until planning audit approves.

**HARD STOP:** Do not implement R13, R10-E/F, R12 feature expansion, or live PSP/payout under this CR.
